Gilead Sciences (GILD)

Company Ticker Sector | Industry Quality PAR
Gilead Sciences GILD Healthcare | Biotechnology 60 5.6%
Current Price (09/20) $66.42
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 22,247.3
Sales Growth Forecast 0.3%
Net Profit Margin 35.8%
Projected Shares Outstanding 1,278.00
EPS - Five year Forecast $6.33
Average P/E Ratio 12.0
Projected Average Price $75.93
Price Appreciation (Annualized) 2.7%
Annual Dividend Yield 2.9%
Projected Annual Return 5.6%
Quality
Financial Strength 94 23.6
EPS Stability 45 11.3
Industry Sales Growth Rate 16.5% 0.2
Industry Net Profit Margin 29.0% 15.4
Calculated Quality Rating 50.5
Fool CAPS

Total Players

3468 Outperforms
92 Underperforms
 

All-Stars (685)

670 Outperforms (98%)
15 Underperforms
 
Fundamental Data Updated: 07/12/2019

MIPAR 8.8%  
Sweet Spot 13.8% - 18.8%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 94 16.7%
RGEN 72 19.1%
BSTC 77 16.0%
BIIB 77 15.4%
CELG 63 19.9%

Top In Healthcare

Ticker Quality PAR
ALGN 96 17.7%
JAZZ 94 16.7%
UNH 97 13.7%
ABBV 88 15.0%
BMY 93 23.9%